Clinical Effectiveness of Wearable Technologies in Chronic Disease Management: Evidence from CaseBased Evaluation and Real-World Applications
Abstract
Wearable technologies have emerged as practical tools for improving the monitoring and management of chronic diseases by enabling continuous data collection, personalized feedback, and remote clinical oversight. This study presents a case-based evaluation of wearable devices deployed in real-world healthcare settings to assess their clinical effectiveness in managing diabetes, cardiovascular conditions, and hypertension. An observational methodology was adopted, involving three patient cohorts utilizing continuous glucose monitors (CGMs), ECG-enabled smartwatches, and activity-based fitness trackers. Clinical outcomes were evaluated using standard metrics including HbA1c levels, arrhythmia detection sensitivity, blood pressure reduction, patient adherence, and cost-effectiveness. Results demonstrate clinically meaningful improvements, including a 0.6–0.9% reduction in HbA1c levels, 93–96% sensitivity in atrial fibrillation detection, and a 6–9 mmHg reduction in systolic blood pressure over a 12-week period. Patient adherence improved by 20–32%, with associated reductions in hospital visits and healthcare costs. While challenges related to data privacy, interoperability, and affordability persist, the findings highlight the potential of wearable technologies as effective, scalable tools for chronic disease management. This study supports the integration of wearables into routine clinical workflows to enable proactive, patient-centered healthcare delivery.